Dysplasia

C2 CryoBalloon™ Ablation System Validated As Effective, Durable And Well-Tolerated By Patients

Retrieved on: 
星期三, 六月 6, 2018
Medicine, Medical terminology, Interventional radiology, Barrett's esophagus, Surgical oncology, Dysplasia, Ablation, Bethesda system, Radiofrequency ablation

In a prospective clinical trial, consecutive BE patients with confirmed neoplasia (low-grade dysplasia, high-grade dysplasia, and/or intramucosal adenocarcinoma) were treated with the C2 CryoBalloon.

Key Points: 
  • In a prospective clinical trial, consecutive BE patients with confirmed neoplasia (low-grade dysplasia, high-grade dysplasia, and/or intramucosal adenocarcinoma) were treated with the C2 CryoBalloon.
  • "Early results from the study suggest that the [C2 CryoBalloon ablation] of ESCN is safe, well-tolerated and highly effective."
  • European clinicians conducted a multicenter, non-randomized cohort study that compared the tolerability of patients treated for Barrett's esophagus after both C2 CryoBalloon ablation and radio frequency ablation.
  • Patients were transfused an average of 1.75 units/month one year prior to C2 CryoBalloon ablation and an average of 0.31 units/month up to 6 months following C2 CryoBalloon ablation.

ASGE Launches Public Service Awareness Campaign to Preempt Esophageal Cancer

Retrieved on: 
星期一, 六月 4, 2018
Medicine, Clinical medicine, Oncology, Diagnostic gastroenterology, RTT, Gynaecology, Polyp, Biopsy, Precancerous condition, Colorectal cancer, Large intestine, Dysplasia

Interested DDW attendees can obtain materials at the ASGE booth (#1733) during DDW June 2-5, 2018 at the Walter E. Washington Convention Center, Washington, DC.

Key Points: 
  • Interested DDW attendees can obtain materials at the ASGE booth (#1733) during DDW June 2-5, 2018 at the Walter E. Washington Convention Center, Washington, DC.
  • The PSA campaign is funded through a partnership with CDx Diagnostics, the provider of WATS3D testing for precancerous cells.
  • Through endoscopy, tissue samples (biopsies) may be obtained, areas of blockage can be opened and active bleeding can be stopped.
  • Polyps in the colon can be removed, which has been shown to prevent colon cancer.

Cervical Dysplasia Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2024

Retrieved on: 
星期四, 五月 24, 2018
Infectious causes of cancer, Gynaecological cancer, Medicine, Cervical intraepithelial neoplasia, Cervical cancer, Dysplasia, Anatomy, Cervical, Health

LONDON, May 24, 2018 /PRNewswire/ -- Global Cervical Dysplasia Market: Scope and Methodology

Key Points: 
  • LONDON, May 24, 2018 /PRNewswire/ -- Global Cervical Dysplasia Market: Scope and Methodology
    This report on the global cervical dysplasia market analyzes the current and future prospects of the market.
  • Growth rates for each segment within the global cervical dysplasia market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
  • This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global cervical cancer market.
  • The global cervical dysplasia market is segmented as follows:
    Global Cervical Dysplasia Market Revenue, by Diagnosis